1. Home
  2. RNXT vs MKTW Comparison

RNXT vs MKTW Comparison

Compare RNXT & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.83

Market Cap

37.4M

Sector

Health Care

ML Signal

HOLD

Logo MarketWise Inc.

MKTW

MarketWise Inc.

HOLD

Current Price

$13.84

Market Cap

34.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNXT
MKTW
Founded
2012
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
37.4M
34.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
RNXT
MKTW
Price
$0.83
$13.84
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$8.00
$20.00
AVG Volume (30 Days)
158.7K
9.5K
Earning Date
01-01-0001
04-27-2026
Dividend Yield
N/A
5.86%
EPS Growth
59.60
260.00
EPS
N/A
1.54
Revenue
$43,000.00
$512,403,000.00
Revenue This Year
$2,995.35
N/A
Revenue Next Year
$219.61
N/A
P/E Ratio
N/A
$8.77
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$0.48
52 Week High
$1.45
$21.74

Technical Indicators

Market Signals
Indicator
RNXT
MKTW
Relative Strength Index (RSI) 37.19 37.65
Support Level $0.82 $13.50
Resistance Level $1.07 $17.39
Average True Range (ATR) 0.06 0.61
MACD -0.01 -0.07
Stochastic Oscillator 9.48 12.39

Price Performance

Historical Comparison
RNXT
MKTW

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About MKTW MarketWise Inc.

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

Share on Social Networks: